Home
Dashboard
Curated content
Startups & Scaleups
New startups
Corporates
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
Service providers
More organizations
Matching tool
Investment heatmap
Themes
Impressum
Companies
Sharp Peptide Biotechnology (Dalian) Group
Save
Sharp Peptide Biotechnology (Dalian) Group
Launch date
Jul 2021
Market cap
-
Enterprise valuation
CAD22—33m
(Dealroom.co estimates May 2023.)
Dalian Liaoning (HQ)
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Sharp Peptide Biotechnology (Dalian) Group funding
Sharp Peptide Biotechnology (Dalian) Group investors
Edit
Date
Investors
Amount
Round
May 2023
*
Sculptor
$4.0m
Series A
Total Funding
CAD5.5m
Recent News about Sharp Peptide Biotechnology (Dalian) Group
Edit